Rights and permissions
About this article
Cite this article
Imipenem/cilastatin value for money in febrile neutropenia. Pharmacoecon. Outcomes News 209, 6 (1999). https://doi.org/10.1007/BF03319513
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03319513